Status:
COMPLETED
Evaluation of the Diagnostic Value of Video-oculography in CANVAS Neuronopathies
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Cerebellar Ataxia
Eligibility:
All Genders
18+ years
Brief Summary
Cerebellar ataxia syndrome with neuropathy and vestibular areflexia (CANVAS) is a genetic pathology of recent discovery (bi-allelic expansion in intron 1 of the RFC1 gene with AAGG repetition). The cl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients followed at the University Hospital of Nîmes between 2018-2021
- Age \> 18 years
- Patients with CANVAS with genetic confirmation (RFC1 gene mutation)
- Patients with axonal neuropathy, autoimmune neuronopathy and anti-MAG neuropathy
- Healthy controls
Exclusion
Key Trial Info
Start Date :
March 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05278091
Start Date
March 15 2022
End Date
March 15 2023
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, Choisir Une Région, France, 30029